[Ala17]-MCH acetate
Katalog-Nummer TP1997L-5mg
Size : 5mg
Marke : TargetMol
[Ala17]-MCH acetate
(Synonyms: [Ala17]-MCH acetate(359784-84-2 free base)) Copy Product Info
[Ala17]-MCH acetate is a selective ligand for MCHR1 with a Ki of 0.16 nM and Kd of 0.37 nM(Eu3+ chelate-labeled). [Ala17]-MCH acetate shows selectivity over MCHR2 with Ki of 34 nM.
![[Ala17]-MCH acetate](/proxy_img/aHR0cHM6Ly9jZG4udGFyZ2V0bW9sLmNvbS9ncm91cDMvTTAwL0EyLzgzL0Nnb2FFR252VUsyRUNLR1lBQUFBQUR2OHdOMDg0OS5wbmc=.png)
For research use only—not for human use. No sales to individuals. Use as intended only.
Select Batch
Purity:98.92%
Appearance:Solid
Color:White
COA MS HPLC
Product Information
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | [Ala17]-MCH acetate is a selective ligand for MCHR1 with a Ki of 0.16 nM and Kd of 0.37 nM(Eu3+ chelate-labeled). [Ala17]-MCH acetate shows selectivity over MCHR2 with Ki of 34 nM. |
| Synonyms | [Ala17]-MCH acetate(359784-84-2 free base) |
| Molecular Weight | 2331.76 |
| Formula | C99H159N29O28S4 |
| Smiles | O=C1N2[C@](CCC2)(21)C(N[C@@H](CSSC[C@@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H]1CCCNC(N)=N)=O)CC3=CC=C(C=C3)O)=O)C(C)C)=O)CCCNC(N)=N)=O)=O)CC(C)C)=O)CCSC)=O)NC([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@H](CCSC)NC([C@H](CC(O)=O)NC([C@@H](NC([C@@H](N)CC(O)=O)=O)CC4=CC=CC=C4)=O)=O)=O)=O)=O)C(N[C@@H](C)C(N[C@@H](CCC(N)=O)C(N[C@H](C(O)=O)C(C)C)=O)=O)=O)=O.CC(O)=O |
| Sequence | Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Ala-Asn-Val |
| Sequence Short | DFDMLRCMLGRVYRPCANV |
| Storage | Store at low temperature,Keep away from moisture Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 125 mg/mL (53.61 mM), Sonication is recommended.  | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+90% Saline: 10 mg/mL (4.29 mM), Solution. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | |||||||||||||||||||||||||||||||